Table 5.
Chemotherapy | Macromolecule | Biomarker | Source | Cellular mechanism | Clinical phenotype | Chemo-resistance | Reference |
---|---|---|---|---|---|---|---|
Carboplatin and paclitaxel | Protein | Heat shock protein 10 (HSP-10) ↓ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 159 |
Carboplatin and paclitaxel | Protein | Matrix metalloproteinase 1 (MMP-1) ↑ | Tissue | Promotes tumour invasion | Non-responder | Intrinsic | 159,178 |
Carboplatin and paclitaxel | DNA | Ecotropic virus integration site 1 protein homolog (EVI1) ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 156,179 |
Carboplatin and paclitaxel | DNA | SH3 domain-containing kinase-binding protein 1 (CIN85) ↓ |
Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 156,180 |
Carboplatin and paclitaxel | DNA | Endophilin A1 (SH3GL2) ↓ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 156,181 |
Carboplatin and paclitaxel | Protein | Ki-67 ↑ | Tissue | Marker for increased cell proliferation | Responder | N/A | 182 |
Carboplatin and paclitaxel | Protein | Adenosine triphosphate–binding cassette sub-family C member 2 (ABCC2) ↓ | Increases apoptosis | Responder | N/A | 182,183 | |
Carboplatin and paclitaxel | mRNA | Insulin-like growth factor-1 (IGF1) ↑ | Tissue | Enhances ovarian cancer cell proliferation through PI3K/Akt/mTOR signalling | Non-responder | Intrinsic | 184,185 |
Carboplatin and paclitaxel | mRNA | Telomerase reverse transcriptase (TERT) ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 186,187 |
Carboplatin and paclitaxel | mRNA | E2F transcription factor 1 (E2F) ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 186,188 |
Carboplatin and paclitaxel | mRNA | Cyclin-dependent kinase inhibitor 1A (CDKN1A) ↓ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 186,189 |
Carboplatin and paclitaxel | mRNA | FBJ murine osteosarcoma viral oncogene homolog (FOS) ↑ | Inhibits apoptosis | Non-responder | Intrinsic | 186,190 | |
Carboplatin and paclitaxel | mRNA | Tumor necrosis factor (TNF) receptor superfamily, member 10A (TNFRSF10A) ↓ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 186 |
Carboplatin and paclitaxel | mRNA | TNF receptor superfamily, member 10C (TNFRSF10C) ↓ | Tissue | Decreased activity as p53-regulated DNA damage-inducible gene | Non-responder | Intrinsic | 186 |
Carboplatin and paclitaxel | mRNA | TNF receptor superfamily, member 10D (TNFRSF10D) ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 186 |
Carboplatin and paclitaxel | mRNA | TNF receptor-associated factor 1 (TRAF-1) ↓ | Tissue | Increases apoptosis | Non-responder | Intrinsic | 186,191 |
Carboplatin and paclitaxel | mRNA | Goosecoid homeobox (GSC) ↑ | Tissue | Increases metastasis | Non-responder | Intrinsic | 186,192 |
Carboplatin and paclitaxel | mRNA | Snail homolog 1 (SNAI 1) ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 186,193 |
Carboplatin and paclitaxel | Protein | Class III β-tubulin (TUBB3) ↑ | Cell line | Cytoskeletal modulation and overcomes stress conditions | Non-responder | Acquired | 194 |
Carboplatin and paclitaxel | Protein | Lewis y ↑ | Tissue | Increases cell adhesion and invasion | Non-responder | Intrinsic | 195,196 |
Carboplatin and paclitaxel | Protein | CD44 ↑ | Tissue | Increases cell adhesion and invasion, increases drug efflux | Non-responder | Intrinsic | 195–197 |
Carboplatin and paclitaxel | Protein | CD147 ↑ | Tissue | Interacts with drug resistance proteins | Non-responder | Intrinsic | 195,198 |
Carboplatin and paclitaxel | Protein | Human epididymis protein 4 (HE4) ↑ | Tissue | Increases tumour cell proliferation | Non-responder | Intrinsic | 195,199 |
Carboplatin and paclitaxel | Protein | Integrin α5β1 ↑ | Tissue | Increases cell adhesion and invasion | Non-responder | Intrinsic | 195,200 |
Carboplatin and paclitaxel | Protein | Integrin αvβ3 ↑ | Tissue | Increases cell adhesion and invasion | Non-responder | Intrinsic | 195,201 |
Carboplatin and paclitaxel | Protein | CD44 ↑ | Tissue | Increases cell adhesion and invasion, increases drug efflux | Non-responder | Intrinsic | 196,197,202 |
Carboplatin and paclitaxel | Protein | IL-8 ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 202,203 |
Carboplatin and paclitaxel | Protein | α-Enolase (ENO1) ↑ | Tissue | Cytoskeleton modulation and inhibition of apoptosis | Non-responder | Intrinsic | 114,204–206 |
Carboplatin and paclitaxel | Protein | Enoyl CoA hydratase (ECH) ↑ | Tissue | Decreases apoptosis | Non-responder | Intrinsic | 114,207 |
Carboplatin and paclitaxel | Protein | Prohibitin (PHB) ↑ | Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 114,208 |
Carboplatin and paclitaxel | Protein | Peroxiredoxin-4 (PRDX4) ↑ | Tissue | Overcomes stress condition and inhibits apoptosis | Non-responder | Intrinsic | 114,209,210 |
Carboplatin and paclitaxel | Protein | Fibrin β ↑ | Tissue | Increases tumour angiogenesis and inhibits apoptosis | Non-responder | Intrinsic | 114,211–213 |
Carboplatin and paclitaxel | Protein | Fibrin γ ↑ | Tissue | Increases tumour angiogenesis and inhibits apoptosis | Non-responder | Intrinsic | 114,211–213 |
Carboplatin and paclitaxel | Protein | Heat shock protein-27 (HSP27) ↑ | Tissue | Increases apoptosis and reduces drug efflux | Responder | Intrinsic | 114,214,215 |
Carboplatin and paclitaxel | Protein | Actin (ACT) ↑ | Tissue | Increases apoptosis | Responder | Intrinsic | 114,216,217 |
Carboplatin and paclitaxel | Protein | Heterogeneous ribonucleoprotein particle (hnRNP) ↑ | Tissue | Increases apoptosis | Responder | Intrinsic | 114,218,219 |
Carboplatin and paclitaxel | Protein | Aldose reductase (ALDR) ↑ | Tissue | Increases apoptosis | Responder | Intrinsic | 114,220,221 |
Carboplatin and paclitaxel | Protein | α-enolase (ENO1) ↑ | Tissue | Cytoskeleton modulation and inhibition of apoptosis | Non-responder | Intrinsic | 204–206,222 |
Carboplatin and paclitaxel | Protein | Elongation factor Tu mitochondrial (TUFM) ↑ |
Tissue | Regulation of autophagy and innate immunity | Non-responder | Intrinsic | 222 |
Carboplatin and paclitaxel | Protein | Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ↑ | Tissue | Increases glycolysis enhancing cell survival | Non-responder | Intrinsic | 222,223 |
Carboplatin and paclitaxel | Protein | Stress-70 protein mitochondrial (GRP75) ↑ |
Tissue | Inhibits apoptosis | Non-responder | Intrinsic | 222,224 |
Carboplatin and paclitaxel | Protein | Annexin A 1 (ANXA1) ↑ | Tissue | Overcomes stress and inhibits apoptosis | Non-responder | Intrinsic | 222 |